CIK: 0001878979
Total reported value
$9.6M
Reporting period: 2022-09-30 · Number of holdings: 1
Two Sigma Ventures, LP disclosed 1 holdings in its latest 13F filing for the period ending 2022-09-30, with total reported value of $9.6M and a quarterly turnover rate of 0.0%.
Browse other institutions with under $100M AUMBrowse other institutions starting with "T"
No strong tilt toward either adding to existing winners or initiating outsized new positions was observed in the latest reported quarter.
No holding changes this quarter
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | RXRX | Recursion Pharmaceuticals-a | Stock-Healthcare | 100.00% | — | -50.00% |
Not enough priced holdings yet to compute performance
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|
| Period | Filed | Type | EDGAR |
|---|---|---|---|
| 2022-09-30 | 2022-11-14 | 13F-HR | View on EDGAR |
| 2022-06-30 | 2022-08-15 | 13F-HR | View on EDGAR |
| 2022-03-31 | 2022-05-16 | 13F-HR | View on EDGAR |
| 2021-12-31 | 2022-02-14 | 13F-HR | View on EDGAR |
Institutions with a similar AUM
CIK 0001600162
Total reported value
$9.7M
1 stks
2015-09-30
Stale — no recent filing
AUM within 0.4% of this institution
CIK 0000098561
Total reported value
$9.7M
1 stks
2021-12-31
Stale — no recent filing
AUM within 0.5% of this institution
CIK 0001406718
Total reported value
$9.5M
3 stks
2023-12-31
Stale — no recent filing
AUM within 0.9% of this institution
Institutions with overlapping top holdings
CIK 0001503556
Total reported value
$60.1M
3 stks
2023-09-30
Stale — no recent filing
1 of the top 5 holdings overlap, including Recursion Pharmaceuticals-a
CIK 0001664974
Total reported value
$55.9M
4 stks
2026-03-31
1 of the top 5 holdings overlap, including Recursion Pharmaceuticals-a
CIK 0001668343
Total reported value
$13.9M
2 stks
2026-03-31
1 of the top 5 holdings overlap, including Recursion Pharmaceuticals-a